
Perimenopause can last four to eight years and bring anywhere from 30 to 100 reported symptoms, which makes it one of the hardest life stages for supplement brands to formulate for. In this Nutritional Outlook Peer Exchange, moderator Jacqueline Jacques, ND, leads a panel of women's health experts through the science, formulation challenges, and market realities behind better perimenopause products. Ayla Barmmer, MS, RD, LDN, founder and CEO of Fullwell; Arzoo Fatima, PharmD, MPH, founder of ZFR Nexus; and Karin Hermoni, PhD, founder of Imagine Health, discuss why one-size-fits-all formulas fall short, how a phenotype-led, evidence-based approach can sharpen product development, and why foundational nutrition still matters. The conversation covers the symptom landscape, common formulation traps, and emerging trends, with practical takeaways for brands, formulators, and ingredient suppliers. Watch to learn how brands can realistically move from products that "cover every symptom" to formulations designed for specific, measurable outcomes.




